PIOPED II Also highlighted the influence of pretest medical probability about the predictive price of CTPA. A normal CTPA experienced a substantial unfavorable predictive benefit for PE at ninety six% and 89% in sufferers with a low or intermediate medical likelihood, respectively, but its unfavorable predictive price was only sixty% https://goldensoarpackage.com/